VVOS: Vivos Therapeutics, Inc. - Summary | Jitta

Vivos Therapeutics, Inc.

NASDAQ:VVOS

Price
$0.50
Loss Chance
57.9%
1.44JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
419 / 713
3,095 / 4,223
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (42)
Recent Business Performance (22)
Financial Strength (22)
Return to Shareholders (0)
Competitive Advantage (35)
Jitta Signs
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 25.75% in the last year
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.44
100.00%
3.05
148.34%
Health Care Services
6.32
15.15%
5.29
7.17%
6.61
33.15%
COMPANY DESCRIPTION
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.